Table 3. Outcomes in incidental ICC or cHCC-CC after liver transplantation for hepatocellular carcinoma.

Case	Age (year); sex	MELD	Type	Size	Pathological findings	AFP (ng/mL)	CEA (ng/mL)	CA 19-9 (U/mL)	Pre-transplant number; maximum size of HCC	Post-transplant number; maximum size of HCC	Outcomes
1	64; female	17	ICC, as incidental	1.8 cm solitary	Well to moderately differentiated adenocarcinoma	17	11.2	80	1; 0.6 cm	6 (necrosis); 1.8 cm	26 months alive
2	55; female	15	cHCC-CC, as misdiagnosis	1.2 cm solitary	Well to moderately differentiated adenocarcinoma	73	6.6	46	2; 2.0 cm	7; 1.0 cm	168 months alive
3	62; male	11	cHCC-CC, as misdiagnosis	1.8 cm solitary	Well to moderately differentiated adenocarcinoma	7	2.4	9	1; 1.3 cm	1; 1.8 cm	90 months alive

AFP, alpha-fetoprotein; CA 19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; HCC, hepatocellular carcinoma; cHCC-CC, combined hepatocellular carcinoma; ICC, intrahepatic cholangiocarcinoma; MELD, model for end-stage liver disease.